Sickle cell disease: a neglected chronic disease of increasing global health importance
Open Access
- 19 September 2014
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 100 (1) , 48-53
Abstract
Sickle cell disease (SCD) is a single gene disorder causing a debilitating systemic syndrome characterised by chronic anaemia, acute painful episodes, organ infarction and chronic organ damage and by a significant reduction in life expectancy. The origin of SCD lies in the malarial regions of the tropics where carriers are protected against death from malaria and hence enjoy an evolutionary advantage. More recently, population migration has meant that SCD now has a worldwide distribution and that a substantial number of children are born with the condition in higher-income areas, including large parts of Europe and North and South America. Newborn screening, systematic clinical follow-up and prevention of sepsis and organ damage have led to an increased life expectancy among people with SCD in many such countries; however, in resource-limited settings where the majority continue to be born, most affected children continue to die in early childhood, usually undiagnosed, due to the lack of effective programmes for its early detection and treatment. As new therapies emerge, potentially leading to disease amelioration or cure, it is of paramount importance that the significant burden of SCD in resource-poor countries is properly recognised.Keywords
This publication has 85 references indexed in Scilit:
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimatesThe Lancet, 2013
- Pulmonary Complications of Sickle Cell DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesisNature Communications, 2010
- Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilizationAmerican Journal of Hematology, 2010
- The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐upAmerican Journal of Hematology, 2010
- Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control studyThe Lancet, 2009
- Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7Journal of Clinical Pathology, 2008
- Asthma is associated with acute chest syndrome and pain in children with sickle cell anemiaBlood, 2006
- Cerebrovascular disease associated with sickle cell pulmonary hypertensionAmerican Journal of Hematology, 2006